drugset / Trial / NCT06260007

Efficacy and Safety Study of Products Based on Tribulus Terrestris, L. in Men With Oligospermia

NCT06260007 ↗

Phase 4 Recruiting 204 enrolled Herbarium Laboratorio Botanico Ltda
RandomizedParallel-groupDouble-blindTreatment

Summary

Efficacy and Safety of Products Based on Tribulus terrestris, L. in Men with Oligospermia. It is expected that the benefits of investigational products outweigh the risks that will be mitigated or carefully managed by the study team.

Timeline

Start
2024-07-12
Primary completion
2026-02
Completion
2026-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Tribulus terrestris Unknown 94 mg —
Subject Tribulus terrestris Unknown 250 mg —
Subject Tribulus terrestris Unknown 280 mg —

Indications